These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2405334)

  • 1. [Effect of antidiabetic treatment in ischemic heart diseases].
    Pogätsa G; Simon J; Koltai MZ; Ballagi-Pordány G; Aranyi Z
    Orv Hetil; 1990 Jan; 131(3):119-26. PubMed ID: 2405334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients.
    Pogatsa G; Koltai MZ; Jermendy G; Simon J; Aranyi Z; Ballagi-Pordany G
    Acta Med Hung; 1992-1993; 49(1-2):39-51. PubMed ID: 1296186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.
    Rana JS; Mukamal KJ; Nesto RW; Morgan JP; Muller JE; Mittleman MA
    Diabet Med; 2005 May; 22(5):576-82. PubMed ID: 15842512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides and arrhythmogenic activity due to myocardial ischaemia.
    Pogátsa G; Koltai MZ; Balkányi I; Dévai I; Kiss V; Köszeghy A
    Acta Physiol Hung; 1988; 71(2):243-50. PubMed ID: 3389169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hypoglycemic sulphonylureas in arrhythmias contributing to the mortality in acute myocardial ischemia.
    Koltai MZ; Aranyi Z; Ballagi-Podány G; Pogátsa G
    Acta Physiol Hung; 1990; 75 Suppl():175-6. PubMed ID: 2371854
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of first and second generation sulphonylureas on cardiotoxicity of strophanthidin in rabbits.
    Ballagi-Pordány G; Köszeghy A; Koltai MZ; Aranyi Z; Pogátsa G
    Diabetes Res; 1989 Dec; 12(4):193-7. PubMed ID: 2637095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents.
    Mathew V; Frye RL; Lennon R; Barsness GW; Holmes DR
    Am J Cardiol; 2004 Feb; 93(4):399-403. PubMed ID: 14969610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.
    Iwamoto Y; Kosaka K; Kuzuya T; Akanuma Y; Shigeta Y; Kaneko T
    Diabet Med; 1996 Apr; 13(4):365-70. PubMed ID: 9162613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas.
    Bilinska M; Potocka J; Korzeniowska-Kubacka I; Piotrowicz R
    Coron Artery Dis; 2007 Sep; 18(6):455-62. PubMed ID: 17700217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart.
    Anselmino M; Ohrvik J; Malmberg K; Standl E; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):177-84. PubMed ID: 18156611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ; Tenenbaum A; Motro M; Adler Y
    Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives.
    Lao B; Czyzyk A; Szutowski M; Szczepanik Z
    Arzneimittelforschung; 1994 Jun; 44(6):727-34. PubMed ID: 8053971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study.
    Gulliford M; Latinovic R
    Diabetes Metab Res Rev; 2004; 20(3):239-45. PubMed ID: 15133756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
    Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
    Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased cardiovascular risk in patients with type 2 diabetes treated with sulfonylurea?].
    Asvold BO; Jonsbu M; Grill V
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2560-4. PubMed ID: 11070997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood glucose concentrations and glycosuria during and after one year of acarbose therapy.
    Aubell R; Boehme K; Berchtold P
    Arzneimittelforschung; 1983; 33(9):1314-8. PubMed ID: 6357206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J; Soszyński P
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.